Economy in transurethral prostatectomy
- PMID: 2410979
- DOI: 10.3109/00365598509180216
Economy in transurethral prostatectomy
Abstract
The economy in transurethral (TURP) versus transvesical (TVP) prostatectomy was evaluated in a prospective randomized study. Forty-three patients were allocated to TURP and 32 to TVP. All patients had clinically benign, medium-sized prostatic hyperplasia. Median postoperative ward time was 15 1/2 days following TVP, compared with 7 days following TURP. Statistically significant differences between the two groups in favour of TURP were also seen in the duration of anaesthesia for prostatectomy, in the amount of antibiotics and i.v. infusions used, as well as in number of postoperative outpatients visits. No difference was observed in number of patients readmitted to hospital within 6 months due to sequelae of the prostatectomy. Postoperative sick-leave was 4 weeks following TVP, compared with 2 weeks for TURP patients. However, in the present study the patients' own expenses related to the operation were small and revealed minor differences in favour of TURP. It is stressed that increasing application of TURP in medium-sized prostatic hyperplasia may imply a substantial reduction in the waiting lists as well as an estimated retrenchment for the Danish community of US $3400 (34000 D.kr.) per patient or at least $4.5 million (45 million D.kr.) per year.
Similar articles
-
Transurethral versus transvesical prostatectomy. Physiological strain.Scand J Urol Nephrol. 1985;19(2):85-91. doi: 10.3109/00365598509180232. Scand J Urol Nephrol. 1985. PMID: 2414844 Clinical Trial.
-
Clinical evaluation of transurethral versus transvesical prostatectomy. A randomized study.Scand J Urol Nephrol. 1984;18(3):201-9. doi: 10.3109/00365598409180184. Scand J Urol Nephrol. 1984. PMID: 6208603
-
Transurethral electrovaporization of the prostate vs. transurethral resection. Results of a multicentric, randomized clinical study on 150 patients.Eur Urol. 1998;33(4):359-64. doi: 10.1159/000019616. Eur Urol. 1998. PMID: 9612677 Clinical Trial.
-
Recent developments in the surgical management of benign prostatic hyperplasia.Urology. 1998 Apr;51(4A Suppl):23-31. doi: 10.1016/s0090-4295(98)00052-1. Urology. 1998. PMID: 9586593 Review.
-
Economic Value of the Transurethral Resection in Saline System for Treatment of Benign Prostatic Hyperplasia in England and Wales: Systematic Review, Meta-analysis, and Cost-Consequence Model.Eur Urol Focus. 2018 Mar;4(2):270-279. doi: 10.1016/j.euf.2016.03.002. Epub 2016 Mar 23. Eur Urol Focus. 2018. PMID: 28753756
Cited by
-
Benign prostatic hyperplasia.Qual Health Care. 1996 Jun;5(2):111-9. doi: 10.1136/qshc.5.2.111. Qual Health Care. 1996. PMID: 10158589 Free PMC article. Review. No abstract available.